[HTML][HTML] Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs
S An, L Fu - EBioMedicine, 2018 - thelancet.com
There are several challenges towards the development and clinical use of small molecule
inhibitors, which are currently the main type of targeted therapies towards intracellular …
inhibitors, which are currently the main type of targeted therapies towards intracellular …
[HTML][HTML] Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs
S An, L Fu - EBioMedicine, 2018 - ncbi.nlm.nih.gov
There are several challenges towards the development and clinical use of small molecule
inhibitors, which are currently the main type of targeted therapies towards intracellular …
inhibitors, which are currently the main type of targeted therapies towards intracellular …
[HTML][HTML] Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs
S An, L Fu - EBioMedicine, 2018 - Elsevier
There are several challenges towards the development and clinical use of small molecule
inhibitors, which are currently the main type of targeted therapies towards intracellular …
inhibitors, which are currently the main type of targeted therapies towards intracellular …
[引用][C] Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs
S An, L Fu - EBioMedicine, 2018 - cir.nii.ac.jp
Small-molecule PROTACs: An emerging and promising approach for the development of
targeted therapy drugs | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
targeted therapy drugs | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs
S An, L Fu - EBioMedicine, 2018 - pubmed.ncbi.nlm.nih.gov
There are several challenges towards the development and clinical use of small molecule
inhibitors, which are currently the main type of targeted therapies towards intracellular …
inhibitors, which are currently the main type of targeted therapies towards intracellular …
[PDF][PDF] Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs
S An, L Fu - 2018 - progenra.com
Small-molecule PROTACs: An emerging and promising approach for the development of
targeted therapy drugs Page 1 Review Small-molecule PROTACs: An emerging and promising …
targeted therapy drugs Page 1 Review Small-molecule PROTACs: An emerging and promising …
Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs.
S An, L Fu - Ebiomedicine, 2018 - europepmc.org
There are several challenges towards the development and clinical use of small molecule
inhibitors, which are currently the main type of targeted therapies towards intracellular …
inhibitors, which are currently the main type of targeted therapies towards intracellular …